{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:28:06Z","timestamp":1792672086876,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["PF\/10\/014"],"award-info":[{"award-number":["PF\/10\/014"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00109-016-1494-0","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T12:28:30Z","timestamp":1481200110000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Doxorubicin-induced chronic dilated cardiomyopathy\u2014the apoptosis hypothesis revisited"],"prefix":"10.1007","volume":"95","author":[{"given":"Cynthia","family":"Kankeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Passante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich J.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","volume":"80","author":"RH Blum","year":"1974","unstructured":"Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80:249\u2013259","journal-title":"Ann Intern Med"},{"key":"1494_CR2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","volume":"32","author":"EA Lefrak","year":"1973","unstructured":"Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302\u2013314","journal-title":"Cancer"},{"key":"1494_CR3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900\u2013905","journal-title":"N Engl J Med"},{"key":"1494_CR4","unstructured":"Ries L, Melbert D, Krapcho M (2007) SEER Cancer Statistics Review, 1975\u20132004. In: Institute NC (ed), Bethesda"},{"key":"1494_CR5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2010.01.019","volume":"270","author":"RA Carvalho","year":"2010","unstructured":"Carvalho RA, Sousa RP, Cadete VJ, Lopaschuk GD, Palmeira CM, Bjork JA, Wallace KB (2010) Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. Toxicology 270:92\u201398","journal-title":"Toxicology"},{"key":"1494_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","volume":"29","author":"L Slordal","year":"2006","unstructured":"Slordal L, Spigset O (2006) Heart failure induced by non-cardiac drugs. Drug Saf 29:567\u2013586","journal-title":"Drug Saf"},{"key":"1494_CR7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.amjcard.2012.10.048","volume":"111","author":"AJ Lenneman","year":"2013","unstructured":"Lenneman AJ, Wang L, Wigger M, Frangoul H, Harrell FE, Silverstein C, Sawyer DB, Lenneman CG (2013) Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy. Am J Cardiol 111:609\u2013612","journal-title":"Am J Cardiol"},{"key":"1494_CR8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808\u2013815","journal-title":"N Engl J Med"},{"key":"1494_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/HCO.0000000000000034","volume":"29","author":"SE Lipshultz","year":"2014","unstructured":"Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL (2014) Anthracycline-related cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol 29:103\u2013112","journal-title":"Curr Opin Cardiol"},{"key":"1494_CR10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710\u2013717","journal-title":"Ann Intern Med"},{"key":"1494_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jphp.12539","volume":"68","author":"AM Meredith","year":"2016","unstructured":"Meredith AM, Dass CR (2016) Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J Pharm Pharmacol 68:729\u2013741","journal-title":"J Pharm Pharmacol"},{"key":"1494_CR12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52:1213\u20131225","journal-title":"J Mol Cell Cardiol"},{"key":"1494_CR13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jphp.12144","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Dass CR (2013) Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes? J Pharm Pharmacol 65:1577\u20131589","journal-title":"J Pharm Pharmacol"},{"key":"1494_CR14","doi-asserted-by":"crossref","unstructured":"De Angelis A, Utbanek K, Capetta D, Berrino L (2016) Doxorubicin cardiotoxicity and target cells: a broader perspective. Cardio-Oncology 2","DOI":"10.1186\/s40959-016-0012-4"},{"key":"1494_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0163-7258(02)00339-X","volume":"97","author":"A Clerk","year":"2003","unstructured":"Clerk A, Cole SM, Cullingford TE, Harrison JG, Jormakka M, Valks DM (2003) Regulation of cardiac myocyte cell death. Pharmacol Ther 97:223\u2013261","journal-title":"Pharmacol Ther"},{"key":"1494_CR16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","volume":"336","author":"G Olivetti","year":"1997","unstructured":"Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S et al (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131\u20131141","journal-title":"N Engl J Med"},{"key":"1494_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0076-6879(94)33011-5","volume":"233","author":"LM Weiner","year":"1994","unstructured":"Weiner LM (1994) Oxygen radicals generation and DNA scission by anticancer and synthetic quinones. Methods Enzymol 233:92\u2013105","journal-title":"Methods Enzymol"},{"key":"1494_CR18","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","volume":"109","author":"D Cardinale","year":"2004","unstructured":"Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C et al (2004) Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109:2749\u20132754","journal-title":"Circulation"},{"key":"1494_CR19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.1999.17.7.2237","volume":"17","author":"EH Herman","year":"1999","unstructured":"Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, Yu ZX, Ferrans VJ (1999) Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17:2237\u20132243","journal-title":"J Clin Oncol"},{"key":"1494_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","volume":"67","author":"VP Empel van","year":"2005","unstructured":"van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ (2005) Myocyte apoptosis in heart failure. Cardiovasc Res 67:21\u201329","journal-title":"Cardiovasc Res"},{"key":"1494_CR21","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","volume":"584","author":"MT Silva","year":"2010","unstructured":"Silva MT (2010) Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 584:4491\u20134499","journal-title":"FEBS Lett"},{"key":"1494_CR22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","volume":"185","author":"M Leist","year":"1997","unstructured":"Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185:1481\u20131486","journal-title":"J Exp Med"},{"key":"1494_CR23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.bbamcr.2010.09.006","volume":"1813","author":"R Ventura-Clapier","year":"2011","unstructured":"Ventura-Clapier R, Garnier A, Veksler V, Joubert F (2011) Bioenergetics of the failing heart. Biochim Biophys Acta 1813:1360\u20131372","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2362.1999.00481.x","volume":"29","author":"A Saraste","year":"1999","unstructured":"Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Investig 29:380\u2013386","journal-title":"Eur J Clin Investig"},{"key":"1494_CR25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1172\/JCI17664","volume":"111","author":"D Wencker","year":"2003","unstructured":"Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497\u20131504","journal-title":"J Clin Invest"},{"key":"1494_CR26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET (2012) Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639\u20131642","journal-title":"Nat Med"},{"key":"1494_CR27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626\u2013629","journal-title":"Science"},{"key":"1494_CR28","doi-asserted-by":"crossref","first-page":"H1374","DOI":"10.1152\/ajpheart.00168.2010","volume":"299","author":"S Bae","year":"2010","unstructured":"Bae S, Siu PM, Choudhury S, Ke Q, Choi JH, Koh YY, Kang PM (2010) Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. Am J Physiol Heart Circ Physiol 299:H1374\u2013H1381","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR29","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.bbadis.2014.09.015","volume":"1842","author":"AC Moreira","year":"2014","unstructured":"Moreira AC, Branco AF, Sampaio SF, Cunha-Oliveira T, Martins TR, Holy J, Oliveira PJ, Sardao VA (2014) Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts. Biochim Biophys Acta 1842:2468\u20132478","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR30","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF (2007) Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67:8839\u20138846","journal-title":"Cancer Res"},{"key":"1494_CR31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/msb.2011.2","volume":"7","author":"HJ Huber","year":"2011","unstructured":"Huber HJ, Dussmann H, Kilbride SM, Rehm M, Prehn JH (2011) Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release. Mol Syst Biol 7:470","journal-title":"Mol Syst Biol"},{"key":"1494_CR32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.411827","author":"J Schmid","year":"2012","unstructured":"Schmid J, Dussmann H, Boukes GJ, Flanagan L, Lindner AU, O'Connor CL, Rehm M, Prehn JH, Huber HJ (2012) Systems analysis of cancer cell heterogeneity in caspase-dependent apoptosis subsequent to mitochondrial outer membrane permeabilisation. J Biol Chem. doi: 10.1074\/jbc.M112.411827","journal-title":"J Biol Chem"},{"key":"1494_CR33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMcibr1214975","volume":"368","author":"DB Sawyer","year":"2013","unstructured":"Sawyer DB (2013) Anthracyclines and heart failure. N Engl J Med 368:1154\u20131156","journal-title":"N Engl J Med"},{"key":"1494_CR34","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1161\/CIRCULATIONAHA.107.689901","volume":"115","author":"S Xiong","year":"2007","unstructured":"Xiong S, Van Pelt CS, Elizondo-Fraire AC, Fernandez-Garcia B, Lozano G (2007) Loss of Mdm4 results in p53-dependent dilated cardiomyopathy. Circulation 115:2925\u20132930","journal-title":"Circulation"},{"key":"1494_CR35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, Adams JM, Strasser A (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036\u20131038","journal-title":"Science"},{"key":"1494_CR36","first-page":"2323","volume":"17","author":"D Li","year":"2013","unstructured":"Li D, Li J, An Y, Yang Y, Zhang SQ (2013) Doxorubicin-induced apoptosis in H9c2 cardiomyocytes by NF-kappaB dependent PUMA upregulation. Eur Rev Med Pharmacol Sci 17:2323\u20132329","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1494_CR37","doi-asserted-by":"crossref","first-page":"H52","DOI":"10.1152\/ajpheart.01046.2005","volume":"291","author":"A Toth","year":"2006","unstructured":"Toth A, Jeffers JR, Nickson P, Min JY, Morgan JP, Zambetti GP, Erhardt P (2006) Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 291:H52\u2013H60","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbrc.2003.09.160","volume":"311","author":"J Huang","year":"2003","unstructured":"Huang J, Ito Y, Morikawa M, Uchida H, Kobune M, Sasaki K, Abe T, Hamada H (2003) Bcl-xL gene transfer protects the heart against ischemia\/reperfusion injury. Biochem Biophys Res Commun 311:64\u201370","journal-title":"Biochem Biophys Res Commun"},{"key":"1494_CR39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.RES.0000143898.67182.4c","volume":"95","author":"K Imahashi","year":"2004","unstructured":"Imahashi K, Schneider MD, Steenbergen C, Murphy E (2004) Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia\/reperfusion injury. Circ Res 95:734\u2013741","journal-title":"Circ Res"},{"key":"1494_CR40","doi-asserted-by":"crossref","first-page":"H2351","DOI":"10.1152\/ajpheart.00783.2002","volume":"284","author":"E Hochhauser","year":"2003","unstructured":"Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub V et al (2003) Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284:H2351\u2013H2359","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.freeradbiomed.2008.09.006","volume":"45","author":"EA Konorev","year":"2008","unstructured":"Konorev EA, Vanamala S, Kalyanaraman B (2008) Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med 45:1723\u20131728","journal-title":"Free Radic Biol Med"},{"key":"1494_CR42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00262-004-0604-y","volume":"54","author":"I Jeremias","year":"2005","unstructured":"Jeremias I, Stahnke K, Debatin KM (2005) CD95\/Apo-1\/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes. Cancer Immunol Immunother 54:655\u2013662","journal-title":"Cancer Immunol Immunother"},{"key":"1494_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lfs.2004.11.029","volume":"77","author":"X Liao","year":"2005","unstructured":"Liao X, Wang X, Gu Y, Chen Q, Chen LY (2005) Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sci 77:160\u2013174","journal-title":"Life Sci"},{"key":"1494_CR44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"1494_CR45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00109-014-1126-5","volume":"92","author":"HJ Huber","year":"2014","unstructured":"Huber HJ, McKiernan RG, Prehn JH (2014) Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches? J Mol Med (Berl) 92:227\u2013237","journal-title":"J Mol Med (Berl)"},{"key":"1494_CR46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","volume":"334","author":"T Ni Chonghaile","year":"2011","unstructured":"Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, Deng J, Anderson KC, Richardson P, Tai YT et al (2011) Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334:1129\u20131133","journal-title":"Science"},{"key":"1494_CR47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.200504082","volume":"171","author":"MB Potts","year":"2005","unstructured":"Potts MB, Vaughn AE, McDonough H, Patterson C, Deshmukh M (2005) Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP. J Cell Biol 171:925\u2013930","journal-title":"J Cell Biol"},{"key":"1494_CR48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200307130","volume":"163","author":"PR Potts","year":"2003","unstructured":"Potts PR, Singh S, Knezek M, Thompson CB, Deshmukh M (2003) Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 163:789\u2013799","journal-title":"J Cell Biol"},{"key":"1494_CR49","doi-asserted-by":"crossref","first-page":"H1603","DOI":"10.1152\/ajpheart.00844.2011","volume":"302","author":"J Shi","year":"2012","unstructured":"Shi J, Zhang L, Zhang YW, Surma M, Mark Payne R, Wei L (2012) Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation. Am J Physiol Heart Circ Physiol 302:H1603\u2013H1613","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0008-6363(02)00646-6","volume":"57","author":"J Nitobe","year":"2003","unstructured":"Nitobe J, Yamaguchi S, Okuyama M, Nozaki N, Sata M, Miyamoto T, Takeishi Y, Kubota I, Tomoike H (2003) Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res 57:119\u2013128","journal-title":"Cardiovasc Res"},{"key":"1494_CR51","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1006\/jmcc.2000.1132","volume":"32","author":"M Yamaoka","year":"2000","unstructured":"Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H (2000) Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 32:881\u2013889","journal-title":"J Mol Cell Cardiol"},{"key":"1494_CR52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejheart.2006.06.002","volume":"9","author":"W Ibe","year":"2007","unstructured":"Ibe W, Saraste A, Lindemann S, Bruder S, Buerke M, Darius H, Pulkki K, Voipio-Pulkki LM (2007) Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment. Eur J Heart Fail 9:160\u2013167","journal-title":"Eur J Heart Fail"},{"key":"1494_CR53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI13779","volume":"109","author":"C Badorff","year":"2002","unstructured":"Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, Ihling C, Zeiher AM, Dimmeler S (2002) Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 109:373\u2013381","journal-title":"J Clin Invest"},{"key":"1494_CR54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12012-007-9004-9","volume":"7","author":"E Purevjav","year":"2007","unstructured":"Purevjav E, Nelson DP, Varela JJ, Jimenez S, Kearney DL, Sanchez XV, DeFreitas G, Carabello B, Taylor MD, Vatta M et al (2007) Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy. Cardiovasc Toxicol 7:255\u2013263","journal-title":"Cardiovasc Toxicol"},{"key":"1494_CR55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-12-2269","volume":"73","author":"AU Lindner","year":"2013","unstructured":"Lindner AU, Concannon CG, Boukes GJ, Cannon MD, Llambi F, Ryan D, Boland K, Kehoe J, McNamara DA, Murray F et al (2013) Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. Cancer Res 73:519\u2013528","journal-title":"Cancer Res"},{"key":"1494_CR56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","volume":"9","author":"M Certo","year":"2006","unstructured":"Certo M, Del Gaizo MV, Nishino M, Wei G, Korsmeyer S, Armstrong SA, Letai A (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9:351\u2013365","journal-title":"Cancer Cell"},{"key":"1494_CR57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.yjmcc.2004.05.024","volume":"37","author":"P Spallarossa","year":"2004","unstructured":"Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S, Rossettin P, Ghigliotti G, Ballestrero A, Patrone F et al (2004) Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 37:837\u2013846","journal-title":"J Mol Cell Cardiol"},{"key":"1494_CR58","first-page":"4592","volume":"62","author":"AC Childs","year":"2002","unstructured":"Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 62:4592\u20134598","journal-title":"Cancer Res"},{"key":"1494_CR59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.105.576785","volume":"113","author":"S Donath","year":"2006","unstructured":"Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V, Willnow T, Bader M, Martin U, Bauersachs J, Wollert KC et al (2006) Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113:1203\u20131212","journal-title":"Circulation"},{"key":"1494_CR60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00280-009-1164-9","volume":"66","author":"KL Thompson","year":"2010","unstructured":"Thompson KL, Rosenzweig BA, Zhang J, Knapton AD, Honchel R, Lipshultz SE, Retief J, Sistare FD, Herman EH (2010) Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemother Pharmacol 66:303\u2013314","journal-title":"Cancer Chemother Pharmacol"},{"key":"1494_CR61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621\u2013632","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1494_CR62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","volume":"80","author":"DG Nicholls","year":"2000","unstructured":"Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev 80:315\u2013360","journal-title":"Physiol Rev"},{"key":"1494_CR63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314","journal-title":"Science"},{"key":"1494_CR64","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S (2007) The failing heart\u2014an engine out of fuel. N Engl J Med 356:1140\u20131151","journal-title":"N Engl J Med"},{"key":"1494_CR65","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cardiores.2003.11.014","volume":"61","author":"M Bilsen van","year":"2004","unstructured":"van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ (2004) Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61:218\u2013226","journal-title":"Cardiovasc Res"},{"key":"1494_CR66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cphy.c150016","volume":"6","author":"D Shao","year":"2015","unstructured":"Shao D, Tian R (2015) Glucose transporters in cardiac metabolism and hypertrophy. Compr Physiol 6:331\u2013351","journal-title":"Compr Physiol"},{"key":"1494_CR67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0005-2736(02)00612-0","volume":"1567","author":"S Hrelia","year":"2002","unstructured":"Hrelia S, Fiorentini D, Maraldi T, Angeloni C, Bordoni A, Biagi PL, Hakim G (2002) Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim Biophys Acta 1567:150\u2013156","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR68","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nn1774","volume":"9","author":"DW Williams","year":"2006","unstructured":"Williams DW, Kondo S, Krzyzanowska A, Hiromi Y, Truman JW (2006) Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci 9:1234\u20131236","journal-title":"Nat Neurosci"},{"key":"1494_CR69","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1038\/sj.emboj.7601295","volume":"25","author":"M Rehm","year":"2006","unstructured":"Rehm M, Huber HJ, Dussmann H, Prehn JH (2006) Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J 25:4338\u20134349","journal-title":"EMBO J"},{"key":"1494_CR70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tcb.2008.06.002","volume":"18","author":"C Sheridan","year":"2008","unstructured":"Sheridan C, Martin SJ (2008) Commitment in apoptosis: slightly dead but mostly alive. Trends Cell Biol 18:353\u2013357","journal-title":"Trends Cell Biol"},{"key":"1494_CR71","doi-asserted-by":"crossref","first-page":"E4079","DOI":"10.1073\/pnas.1315587110","volume":"110","author":"C Putinski","year":"2013","unstructured":"Putinski C, Abdul-Ghani M, Stiles R, Brunette S, Dick SA, Fernando P, Megeney LA (2013) Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 110:E4079\u2013E4087","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1494_CR72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0733-8651(05)70198-3","volume":"19","author":"J Narula","year":"2001","unstructured":"Narula J, Arbustini E, Chandrashekhar Y, Schwaiger M (2001) Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 19:113\u2013126","journal-title":"Cardiol Clin"},{"key":"1494_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2736(80)90145-5","volume":"597","author":"E Goormaghtigh","year":"1980","unstructured":"Goormaghtigh E, Chatelain P, Caspers J, Ruysschaert JM (1980) Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim Biophys Acta 597:1\u201314","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR74","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/bi971475e","volume":"36","author":"J Vasquez-Vivar","year":"1997","unstructured":"Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA Jr, Kalyanaraman B (1997) Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36:11293\u201311297","journal-title":"Biochemistry"},{"key":"1494_CR75","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0024-3205(00)00990-5","volume":"68","author":"MF Xu","year":"2001","unstructured":"Xu MF, Tang PL, Qian ZM, Ashraf M (2001) Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci 68:889\u2013901","journal-title":"Life Sci"},{"key":"1494_CR76","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/stem.2015","volume":"33","author":"SI Hashem","year":"2015","unstructured":"Hashem SI, Perry CN, Bauer M, Han S, Clegg SD, Ouyang K, Deacon DC, Spinharney M, Panopoulos AD, Izpisua Belmonte JC et al (2015) Brief report: oxidative stress mediates cardiomyocyte apoptosis in a human model of Danon disease and heart failure. Stem Cells 33:2343\u20132350","journal-title":"Stem Cells"},{"key":"1494_CR77","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","volume":"87","author":"K Sinha","year":"2013","unstructured":"Sinha K, Das J, Pal PB, Sil PC (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87:1157\u20131180","journal-title":"Arch Toxicol"},{"key":"1494_CR78","doi-asserted-by":"crossref","first-page":"H1832","DOI":"10.1152\/ajpheart.01047.2009","volume":"298","author":"K Vedam","year":"2010","unstructured":"Vedam K, Nishijima Y, Druhan LJ, Khan M, Moldovan NI, Zweier JL, Ilangovan G (2010) Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice. Am J Physiol Heart Circ Physiol 298:H1832\u2013H1841","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jphp.12324","volume":"67","author":"O Tacar","year":"2015","unstructured":"Tacar O, Indumathy S, Tan ML, Baindur-Hudson S, Friedhuber AM, Dass CR (2015) Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells. J Pharm Pharmacol 67:231\u2013243","journal-title":"J Pharm Pharmacol"},{"key":"1494_CR80","doi-asserted-by":"crossref","unstructured":"Dhingra R, Dhingra A, Jayas R, Kirshenbaum LA (2016) Ellagic acid suppresses mitophagy-induced necrotic cell death during doxorubicin cardiotoxicity","DOI":"10.1161\/res.117.suppl_1.25"},{"key":"1494_CR81","doi-asserted-by":"crossref","unstructured":"Weiner A, Kaminaris A, Kobayashi S, Gerdes M, Liang Q (2016) The role of mitophagy in doxorubicin-induced cardiomyocyte death. In: Meeting EB (ed) Faseb J","DOI":"10.1096\/fasebj.30.1_supplement.1015.2"},{"key":"1494_CR82","doi-asserted-by":"crossref","first-page":"25535","DOI":"10.1074\/jbc.M400944200","volume":"279","author":"S Wang","year":"2004","unstructured":"Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem 279:25535\u201325543","journal-title":"J Biol Chem"},{"key":"1494_CR83","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrc.2016.58","volume":"16","author":"G Ichim","year":"2016","unstructured":"Ichim G, Tait SW (2016) A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer 16:539\u2013548","journal-title":"Nat Rev Cancer"},{"key":"1494_CR84","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1242\/jcs.024547","volume":"121","author":"TV Murray","year":"2008","unstructured":"Murray TV, McMahon JM, Howley BA, Stanley A, Ritter T, Mohr A, Zwacka R, Fearnhead HO (2008) A non-apoptotic role for caspase-9 in muscle differentiation. J Cell Sci 121:3786\u20133793","journal-title":"J Cell Sci"},{"key":"1494_CR85","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.104.500447","volume":"112","author":"N Nagaya","year":"2005","unstructured":"Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M et al (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:1128\u20131135","journal-title":"Circulation"},{"key":"1494_CR86","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12012-012-9177-8","volume":"12","author":"AF Branco","year":"2012","unstructured":"Branco AF, Sampaio SF, Moreira AC, Holy J, Wallace KB, Baldeiras I, Oliveira PJ, Sardao VA (2012) Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts. Cardiovasc Toxicol 12:326\u2013340","journal-title":"Cardiovasc Toxicol"},{"key":"1494_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300433","author":"S Hector","year":"2012","unstructured":"Hector S, Rehm M, Schmid J, Kehoe J, McCawley N, Dicker P, Murray F, McNamara D, Kay EW, Concannon CG et al (2012) Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy. Gut (in press). doi: 10.1136\/gutjnl-2011-300433","journal-title":"Gut"},{"key":"1494_CR88","doi-asserted-by":"crossref","unstructured":"Huber HJ, Dussmann H, Wenus J, Kilbride S, Prehn JH (2011) Mathematical modelling of the mitochondrial apoptosis pathway BBA Mol Cell Res x","DOI":"10.1016\/j.bbamcr.2010.10.004"},{"key":"1494_CR89","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3164\/jcbn.10-64","volume":"47","author":"Z Junjing","year":"2010","unstructured":"Junjing Z, Yan Z, Baolu Z (2010) Scavenging effects of dexrazoxane on free radicals. J Clin Biochem Nutr 47:238\u2013245","journal-title":"J Clin Biochem Nutr"},{"key":"1494_CR90","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","volume":"1832","author":"E Dirkx","year":"2013","unstructured":"Dirkx E, da Costa Martins PA, De Windt LJ (2013) Regulation of fetal gene expression in heart failure. Biochim Biophys Acta 1832:2414\u20132424","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR91","doi-asserted-by":"crossref","first-page":"e58841","DOI":"10.1371\/journal.pone.0058841","volume":"8","author":"S Vandenwijngaert","year":"2013","unstructured":"Vandenwijngaert S, Pokreisz P, Hermans H, Gillijns H, Pellens M, Bax NA, Coppiello G, Oosterlinck W, Balogh A, Papp Z et al (2013) Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling. PLoS One 8:e58841","journal-title":"PLoS One"},{"key":"1494_CR92","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230\u2013233","journal-title":"Nature"},{"key":"1494_CR93","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"M Vander Heiden","year":"2009","unstructured":"Vander Heiden M, Cantley L, Thomson C (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033","journal-title":"Science"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1494-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:26:06Z","timestamp":1718936766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1494-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1494-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}